Psychobiological Effects of Meditation on Offenders With Psychopathy

September 3, 2016 updated by: Ivana Buric, Coventry University

Psychological and Biological Effects of Intensive Mindfulness Meditation on Offenders With Dangerous and Severe Personality Disorder: A Randomised Controlled Trial

The investigators aim to explore the psychobiological effects of a 5-day meditation intervention on offenders within dangerous and severe personality disorders (DSPD) unit at HMP Whitemoor. DSPD unit accommodates offenders with psychopathy or with two or more personality disorders. DPSD unit provides them with a 5-year rehabilitation programme that consists of group and individual therapy and aims to improve their self-regulation.

This project includes a total of 60 participants and has two major methodological innovations. First, it will include yoga as an active control group that will be matched to the meditation intervention (which means it will have the same length and the same social components) and a passive control group that will be following their usual regimen. Thus, the effects of meditation will be contrasted with another type of intervention and with not receiving any intervention.

The second methodological innovation is the combination of psychological and biological measures. Psychological measures include questionnaires (emotion regulation, mindfulness, stress) and cognitive measures (attention,empathy,behavioural control). Biological measures include EEG to measure brain activity related to empathy; gene expression and protein interlukin-6 to measure changes in immune system; and stress related hormone cortisol. The investigators also aim to determine to whom does meditation benefit the most by exploring how initial expectations of meditation, personality, mood and previous life adversity predict outcomes of meditation or yoga. The data will be collected at three time points: at baseline, immediately after and 10 weeks after the 5-day intervention.

The investigators expect that meditation and yoga will similarly improve mental and physical health. If this hypothesis are confirmed, these results will extend previous findings on the benefits of meditation and yoga to vulnerable populations, and would provide a cost-effective addition to prisoner rehabilitation.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male offenders with dangerous and severe personality disorder aged 18-65 who will remain in the prison until at least February 2017.

Exclusion Criteria:

  • Major psychiatric or neurological disorders, previous meditation or yoga experience, unable to follow instructions in English,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness
No Intervention: Wait-list
Active Comparator: Hatha Yoga

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline emotional regulation
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Difficulties in Emotion Regulation Scale
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline attention
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Attention Network Task
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline self-awareness
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Mindful Attention Awareness Scale
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline inflammatory gene expression
Time Frame: Before the intervention and on the final day of the intervention
Before the intervention and on the final day of the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline social learning
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Social Learning Task (Diaconescu et al., 2014)
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline risk-taking
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Risk-taking Task (Tymula et al., 2012)
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline empathy
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Self-assessment Manikin (Seara & Cardoso, 2012).
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline stress
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Perceived Stress Scale
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Change from baseline affective states
Time Frame: Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up
Profile of Mood States
Before the intervention, up to 2 weeks after the intervention and at 10-18 week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Anticipated)

February 1, 2017

Study Completion (Anticipated)

February 1, 2017

Study Registration Dates

First Submitted

August 30, 2016

First Submitted That Met QC Criteria

September 3, 2016

First Posted (Estimate)

September 9, 2016

Study Record Updates

Last Update Posted (Estimate)

September 9, 2016

Last Update Submitted That Met QC Criteria

September 3, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 13274-24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Yoga

Clinical Trials on Yoga

3
Subscribe